Luina Bio And XING Technologies Set To Manufacture New And Fast SARS-CoV-2 Diagnostic Kit
13 July 2020 Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to co-develop and manufacture a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnostic kit. The COVID-19 detection technology is…
BioWorld Recognized for Excellence of Information & Intelligence to Biopharmaceutical Industry
13 July 2020 BioWorld™, a part of Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, was recognized last month for excellence in publishing by the Specialized Information Publishers…
PolyNovo hit record US sales in June, announce first sales in UK
10 July 2020 Highlights: -Record US Sales in June -First Sales in UK -FY20 Sales Guidance US June 2020 was a new record sales month in the US. Since the record sales month announced on 7 April PolyNovo…
Australian universities join forces to tackle inflammatory lung disease
8 July 2020 A new spin-out company, RAGE Biotech, will develop novel therapies designed to help patients with chronic inflammatory lung diseases such as severe asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD), supported by investment from…
MTPConnect to Deliver $47M Diabetes and Cardiovascular Disease Accelerator Program
13 July 2020 The Australian Government has announced that MTPConnect will operate the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease. The announcement was made jointly by Hon Greg Hunt MP, the Minister for…
Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer
9 July 2020 BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, today announced that Chad Briscoe, Ph.D. has joined the organization’s leadership team as Chief Scientific Officer. In this role, Dr.…
CSIRO/Doherty Institute Select Recce Compounds for Priority 1 SARS-CoV-2 Antiviral Screening Program
9 July 2020 Highlights: • RECCE® 327 and New RECCE® 529 compounds were selected for their unique mechanism of actions against hyper-mutation, as indicated on bacteria and viruses (respectively) • Testing program will be conducted by CSIRO &…
Application granted for OMX Solutions TriFixTM Plating System inclusion on Prostheses List
7 July 2020 OMX Solutions Pty Ltd is delighted to announce the inclusion of its’ latest custom-made medical device (CMMD), the TriFixTM plating system, on the Prostheses List. The Prosthesis List and TriFixTM plating systems listing becomes effective…
LBT Teams With Global Clinical Diagnostic Company Beckman Coulter
7 July 2020 Australian medical technology company LBT Innovations Limited, a leader in medical technology automation using artificial intelligence, is pleased to announce a Marketing Agent Agreement with Beckman Coulter, Inc. (Beckman Coulter), a global leader in clinical…
In Fight Against COVID-19, CSL Behring Begins Trial to Evaluate Monoclonal Antibody (CSL312) for Respiratory Distress
6 July 2020 Global biotherapeutics leader CSL Behring today announced that the first patient has been enrolled in its Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagonist monoclonal antibody) to treat patients suffering from severe…
ANDHealth releases the first detailed report on Australia’s digital health industry
3 July 2020 Three years in the making, ANDHealth are proud to bring you a brand new report – Digital Health: The Sleeping Giant of Australia’s Health Technology Industry. Packed with data and information we’ve collected from the…
KPMG – The Digital Delta Innovation Trends Survey 2020
3 July 2020 Business leaders in recent years have consistently indicated that innovation is amongst their top priorities. KPMG want to help you better understand how your Australian peers’ innovation perspectives and actions are changing, as we adjust…
